HANGZHOU, China and SHANGHAI and BOSTON, Nov. 19, 2025 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as "Lynk Pharmaceuticals"), a clinical-stage innovative drug development ...
The U.S. Air Force's two experimental F-15EX Eagle II fighters return from a test mission over the Gulf of Mexico on Aug. 2, 2023. (Tech. Sgt. John McRell/U.S. Air Force) WASHINGTON — The U.S. Air ...
Hosted on MSN
Summit Therapeutics outlines ivonescimab progress with key Phase III data expected mid-2025
Co-CEO Bob Duggan highlighted significant progress with ivonescimab, Summit Therapeutics' lead investigational asset, emphasizing its potential impact on unmet medical needs. Key milestones included ...
Nektar Therapeutics has two Phase IIb studies underway for rezpeg in atopic dermatitis and severe alopecia areata, with read-outs expected in 1H'25. Success in either indication would significantly ...
PERTH AMBOY — The second phase of a massive three-phase project to rebuild NJ Transit's Raritan River Bridge began on a sweltering Tuesday, June 24. "So many of the coastal towns, of which I live in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback